Latife Arzu ARAL, Mehmet Ali ERGUN, Hayrunnisa BOLAY

Cellular iron storage and trafficking are affected by GTN stimulation in primary glial and meningeal cell culture

A well-balanced intracellular iron trafficking in glial cells plays a role in homeostatic processes. Elevated intracellular iron triggers oxidative stress and cell damage in many neurological disorders, including migraine. This study aimed to investigate the effects of glyceryl trinitrate (GTN), on cellular iron homeostasis, matrixmetalloproteinase (MMP)-9, and calcitonin gene related peptide (CGRP) receptor (CRLR/CGRPR1) production in microglia, astrocyte, and meningeal cell cultures. Primary glial and meningeal cells in culture were exposed to GTN for 24 h. Messenger RNA expression was assessed using qPCR. Iron accumulation was visualized via modified Perl’s histochemistry. MMP-9 levels in cell culture supernatants were measured using ELISA. Ferritin and CRLR/CGRPR1 proteins were visualized via immunofluorescence staining. Nitric oxide production increased significantly with GTN in meningeal and glial cells. GTN significantly increased the expression of the storage protein ferritin for all three cell types, but ferritin-L for meningeal cells and microglia. Iron trafficking associated with the efflux protein ferroportin and influx protein divalent metal transporter (DMT)1 was affected differently in all three cell types. MMP-9 expression was increased in astrocytes. GTN stimulation increased both CRLR/CGRPR1 expression, and immunostaining was apparent in microglia and meningeal cells. This study showed for the first time that GTN modulates intracellular iron trafficking regulated by storage and transport proteins expressed in meningeal cells and glia. CRLR/CGRPR1 expression might be related to altered iron homeostasis and they both may stimulate nociceptive pathways activated in migraine. These molecules expressed differently in glial and meningeal cells in response to GTN may bring not only new targets forward in treatment but also prevention in migraine.

Keywords:

Migraine, microglia, astrocyte, meningeal cell, iron ferritin, MMP-9, CGRPR,

PDF

___

Benes L, 2004, J CLIN PATHOL, V57, P172, DOI 10.1136/jcp.2003.12997
Bolay H., 2004, NEUROBIOLOGY MIGRAIN, P107
Christiansen I, 1999, CEPHALALGIA, V19, P660, DOI 10.1046/j.1468-2982.1999.019007660.x
Edvinsson L, 2018, HEADACHE, V58, P33, DOI 10.1111/head.13305
Finazzi D, 2014, ARCH TOXICOL, V88, P1787, DOI 10.1007/s00204-014-1329-0
Gawlak M, 2009, NEUROSCIENCE, V158, P167, DOI 10.1016/j.neuroscience.2008.05.045
Goadsby PJ, 2012, ANN INDIAN ACAD NEUR, V15, P15, DOI 10.4103/0972-2327.99993
Gupta VK, 2009, EXPERT REV NEUROTHER, V9, P1595, DOI [10.1586/ern.09.103, 10.1586/ERN.09.103]
Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227
Hay DL, 2017, HEADACHE, V57, P625, DOI 10.1111/head.13064
Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200
Karsan N, 2015, CURR OPIN NEUROL, V28, P250, DOI 10.1097/WCO.0000000000000191
Kaur C, 2009, PROG NEUROBIOL, V87, P264, DOI 10.1016/j.pneurobio.2009.01.003
Kruit MC, 2009, CEPHALALGIA, V29, P351, DOI 10.1111/j.1468-2982.2008.01723.x
LEVI S, 1988, J BIOL CHEM, V263, P18086 .
Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666
Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140
Morara S, 2008, EUR J NEUROSCI, V28, P2213, DOI 10.1111/j.1460-9568.2008.06514.x
Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008
Olesen J, 2008, PHARMACOL THERAPEUT, V120, P157, DOI 10.1016/j.pharmthera.2008.08.003
Oshiro S, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/378278
Rathore KI, 2008, J NEUROSCI, V28, P12736, DOI 10.1523/JNEUROSCI.3649-08.2008
Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490
Reuter U, 2002, ANN NEUROL, V51, P507, DOI 10.1002/ana.10159
Ricci G, 2009, J BIOL PHYS, V35, P317, DOI 10.1007/s10867-009-9157-9
Santambrogio P, 1996, BIOCHEM J, V314, P139, DOI 10.1042/bj3140139
Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274
Schulz K, 2011, J NEUROSCI, V31, P13301, DOI 10.1523/JNEUROSCI.2838-11.2011
Sengupta R, 2009, J NEUROSCI, V29, P2534, DOI 10.1523/JNEUROSCI.5865-08.2009
Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866
Tepper SJ, 2012, HEADACHE, V52, P236, DOI 10.1111/j.1526-4610.2011.02056.x
Urrutia P, 2013, J NEUROCHEM, V126, P541, DOI 10.1111/jnc.12244
Zarruk JG, 2015, NEUROBIOL DIS, V81, P93, DOI 10.1016/j.nbd.2015.02.001